Starpharma Holdings Limited (OTCMKTS:SPHRY) Sees Significant Increase in Short Interest

Starpharma Holdings Limited (OTCMKTS:SPHRY) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 4,500 shares, an increase of 66.7% from the October 15th total of 2,700 shares. Based on an average daily volume of 5,500 shares, the short-interest ratio is presently 0.8 days.

Starpharma Trading Up 8.3 %

Shares of OTCMKTS:SPHRY traded up $0.06 during trading on Friday, reaching $0.74. The stock had a trading volume of 9,306 shares, compared to its average volume of 4,474. The company has a current ratio of 4.94, a quick ratio of 4.58 and a debt-to-equity ratio of 0.07. The stock has a fifty day simple moving average of $0.66 and a two-hundred day simple moving average of $0.66. Starpharma has a 52 week low of $0.52 and a 52 week high of $1.33.

About Starpharma

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.